1,025
Views
0
CrossRef citations to date
0
Altmetric
Gastroenterology

Investigation of the prevalence and risk factors of Helicobacter pylori infection and the value of different gastric cancer screening methods in a low-risk region of gastric cancer in China

, , , , , , ORCID Icon & show all
Article: 2243988 | Received 18 Jun 2023, Accepted 31 Jul 2023, Published online: 05 Sep 2023

References

  • Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):1–8. doi: 10.1053/j.gastro.2017.04.022.
  • Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–490. doi: 10.1002/ijc.28999.
  • Chiang TH, Chang WJ, Chen SL, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021;70:243–250.
  • Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113–2121. doi: 10.1136/gutjnl-2020-320839.
  • Owyang SY, Luther J, Kao JY. Helicobacter pylori: beneficial for most? Expert Rev Gastroenterol Hepatol. 2011;5(6):649–651. doi: 10.1586/egh.11.69.
  • Laszewicz W, Iwańczak F, Iwańczak B. Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions. Adv Med Sci. 2014;59(1):147–150. doi: 10.1016/j.advms.2014.01.003.
  • Dore MP, Malaty HM, Graham DY, et al. Risk factors associated with Helicobacter pylori infection among children in a defined geographic area. Clin Infect Dis. 2002;35(3):240–245. doi: 10.1086/341415.
  • Bastos J, Peleteiro B, Pinto H, et al. Prevalence, incidence and risk factors for Helicobacter pylori infection in a cohort of Portuguese adolescents (EpiTeen). Dig Liver Dis. 2013;45(4):290–295. doi: 10.1016/j.dld.2012.11.009.
  • Shi R, Xu S, Zhang H, et al. Prevalence and risk factors for Helicobacter pylori infection in Chinese populations. Helicobacter. 2008;13(2):157–165. doi: 10.1111/j.1523-5378.2008.00586.x.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
  • Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198–205. doi: 10.1007/s10120-015-0469-0.
  • Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels – ABC method. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(7):405–414. doi: 10.2183/pjab.87.405.
  • Ni DQ, Lyu B, Bao HB[, et al. Comparison of different serological methods in screening early gastric cancer. ]. Zhonghua Nei Ke Za Zhi. 2019;58:294–300.
  • Cai Q, Zhu C, Yuan Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–1587. doi: 10.1136/gutjnl-2018-317556.
  • He Y, Wang Y, Luan F, et al. Chinese and global burdens of gastric cancer from 1990 to 2019. Cancer Med. 2021;10(10):3461–3473. doi: 10.1002/cam4.3892.
  • Wang KJ, Wang RT. Meta-analysis on the epidemiology of Helicobacter pylori infection in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24:443–446.
  • Miki K, Urita Y. Using serum pepsinogens wisely in clinical practice. J Dig Dis. 2007;8(1):8–14. doi: 10.1111/j.1443-9573.2007.00278.x.
  • Bang CS, Lee JJ, Baik GH. Prediction of chronic atrophic gastritis and gastric neoplasms by serum pepsinogen assay: a systematic review and meta-analysis of diagnostic test accuracy. J Clin Med. 2019;8(5):657. doi: 10.3390/jcm8050657.
  • Zhou JP, Liu CH, Liu BW, et al. Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test. Front Cell Infect Microbiol. 2022;12:980399. doi: 10.3389/fcimb.2022.980399.
  • Ford AC, Mahadeva S, Carbone MF, et al. Functional dyspepsia. Lancet. 2020;396(10263):1689–1702. doi: 10.1016/S0140-6736(20)30469-4.
  • Lee YC, Dore MP, Graham DY. Diagnosis and treatment of Helicobacter pylori infection. Annu Rev Med. 2022;73:183–195. doi: 10.1146/annurev-med-042220-020814.
  • Yan L, Chen Y, Chen F, et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology. 2022;163(1):154–162.e3. doi: 10.1053/j.gastro.2022.03.039.
  • Leja M, Grinberga-Derica I, Bilgilier C, et al. Review: epidemiology of Helicobacter pylori infection. Helicobacter. 2019;24 (1):e12635. doi: 10.1111/hel.12635.
  • Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868–876. doi: 10.1111/apt.14561.
  • Di Mario F, Crafa P, Barchi A, et al. Pepsinogen II in gastritis and Helicobacter pylori infection. Helicobacter. 2022;27(2):e12872. doi: 10.1111/hel.12872.
  • Okuda M, Lin Y, Mabe K, et al. Serum pepsinogen values in Japanese junior high school students with reference to Helicobacter pylori infection. J Epidemiol. 2020;30(1):30–36. doi: 10.2188/jea.JE20180119.
  • Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol. 2008;6(2):174–179. doi: 10.1016/j.cgh.2007.11.016.
  • Kotilea K, Bontems P, Epidemiology TE. Diagnosis and risk factors of Helicobacter pylori infection. Adv Exp Med Biol. 2019;1149:17–33.
  • Ogihara A, Kikuchi S, Hasegawa A, et al. Relationship between Helicobacter pylori infection and smoking and drinking habits. J Gastroenterol Hepatol. 2000;15(3):271–276. doi: 10.1046/j.1440-1746.2000.02077.x.
  • Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the 13C-Urea breath test. BMC Public Health. 2013;13:1215. doi: 10.1186/1471-2458-13-1215.
  • Weisse ME, Eberly B, Person DA. Wine as a digestive aid: comparative antimicrobial effects of bismuth salicylate and red and white wine. BMJ. 1995;311(7021):1657–1660. doi: 10.1136/bmj.311.7021.1657.
  • Murray LJ, Lane AJ, Harvey IM, et al. Inverse relationship between alcohol consumption and active Helicobacter pylori infection: the Bristol Helicobacter project. Am J Gastroenterol. 2002;97(11):2750–2755. doi: 10.1111/j.1572-0241.2002.07064.x.
  • Liszt KI, Walker J, Somoza V. Identification of organic acids in wine that stimulate mechanisms of gastric acid secretion. J Agric Food Chem. 2012;60(28):7022–7030. doi: 10.1021/jf301941u.
  • Li D, Bautista MC, Jiang SF, et al. Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: a population-based study. Am J Gastroenterol. 2016;111(8):1104–1113. doi: 10.1038/ajg.2016.188.